CN Stock MarketDetailed Quotes

Jiangxi Synergy Pharmaceutical (300636)

Watchlist
  • 7.82
  • +0.05+0.64%
Market Closed Apr 30 15:00 CST
3.28BMarket Cap46.27P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jiangxi Synergy Pharmaceutical (300636) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical raw material729.35M88.02%
Pharmaceutical intermediates95.7M11.55%
Other products3.61M0.43%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing825.05M99.56%
Other business3.61M0.43%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Export sales668.94M80.73%
Domestic sales159.72M19.27%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.84%
Sample Name
Sample Code
 +5.69%
Sample Name
Sample Code
 +5.17%
4
CHINA OILFIELD
02883
+4.76%
5
SINOPEC CORP
00386
+2.90%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Iran has announced its latest negotiation proposal: all issues should be resolved within 30 days, with the focus on 'ending the war' rather Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -